Method for determining beta-subunit of human prolyl 4-hydroxylase by
immunoassay to detect hepatic disease
    1.
    发明授权
    Method for determining beta-subunit of human prolyl 4-hydroxylase by immunoassay to detect hepatic disease 失效
    通过免疫测定法检测肝脏疾病的人脯氨酰4-羟化酶的β-亚单位的方法

    公开(公告)号:US5137807A

    公开(公告)日:1992-08-11

    申请号:US380751

    申请日:1989-07-17

    摘要: The present invention is directed to a method for detecting hepatic diseases which are associated with fibrosis by determining the level of human prolyl hydroxylase in a serum sample which comprises:(a) contacting a serum sample of a patient suspected of having said hepatic disease associated with fibrosis with a monoclonal antibody specific to the .beta.-subunit of human prolyl hydroxylase to form an antigen antibody complex bound on a solid support;(b) contacting said antigen antibody complex bound on said solid support with an enzyme-labeled monoclonal or enzyme-labeled polyclonal antibody specific to human prolyl hydroxylase to form an antibody antigen enzyme-labeled antibody complex; and(c) measuring the amount of enzyme activity of said bound antibody antigen enzyme-labeled antibody complex to determine the level of human prolyl hydroxylase present in said serum sample.

    摘要翻译: 本发明涉及通过测定血清样品中人脯氨酰羟化酶水平来检测与纤维化相关的肝病的方法,该方法包括:(a)使疑似患有所述肝病的患者的血清样品与 纤维化与对人脯氨酰羟化酶的β亚单位特异的单克隆抗体形成结合在固体支持物上的抗原抗体复合物; (b)将结合在所述固体支持物上的所述抗原抗体复合物与人脯氨酰羟化酶特异性的酶标记的单克隆或酶标记的多克隆抗体接触以形成抗体抗原酶标记的抗体复合物; 和(c)测量所述结合的抗体抗体酶标记的抗体复合物的酶活性的量以确定存在于所述血清样品中的人脯氨酰羟化酶的水平。